Posts by: Joana Carvalho

News

The U.S. Food and Drug Administration (FDA) approved a new label for Stiolto Respimat (a combination therapy of tiotropium bromide and olodaterol) based on data from clinical trials showing ... Read more

August 7, 2018August 7, 2018

Hospitalized COPD Patients with AFib More Likely to Develop Complications, Study Reports

News

Hospitalized patients with chronic obstructive pulmonary disease (COPD) who also suffer from atrial fibrillation (AFib), a condition where the heart beats faster, have a greater risk of developing liver ... Read more

Posts by: Joana Carvalho

Joana Carvalho

FDA Approves New Label for Stiolto Respimat Showing Efficacy Against COPD Flare-ups

Hospitalized COPD Patients with AFib More Likely to Develop Complications, Study Reports

Pin It on Pinterest